The myocardial protective effects of a moderate-potassium adenosine-lidocaine cardioplegia in pediatric cardiac surgery

To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.jtcvs.2008.03.025 Byline: Zhen-Xiao Jin (a), Sheng-Li Zhang (a), Xi-Ming Wang (a), Sheng-Hui Bi (a), Mei Xin (a), Jing-Jun Zhou (b), Qin Cui (a), Wei-Xun Duan (a), Hong-Bing Wang (a), Ding-Hua Yi (a) Abbreviations: AL, adenosine-lidocaine; CPB, cardiopulmonary bypass; cTnI, cardiac troponin I; HP, high potassium; HPAL, high-potassium adenosine-lidocaine; ICU, intensive care unit; MPAL, moderate-potassium adenosine-lidocaine; MUF, modified ultrafiltration; PRBC, packed red blood cell Abstract: We sought to evaluate a moderate-potassium cardioplegic solution using adenosine and lidocaine as the arresting and protecting cardioprotective combination in pediatric cardiac surgery. Author Affiliation: (a) Institute of Cardiovascular Surgery, Xijing Hospital, the Fourth Military Medical University, Xi'an, China (b) Department of Physiology, the Fourth Military Medical University, Xi'an, China Article History: Received 14 January 2008; Revised 22 February 2008; Accepted 20 March 2008 Article Note: (footnote) Supported by the National 11th Five-year Science and Technology Supporting Project of China (2006BAI01A08) and Shaanxi Province Science and Technology Fund (2007K14-05[10]) and (2006K13-G1[2]).